| Hepatitis B vaccination and the risk of multiple sclerosis A Ascherio, SM Zhang, MA Hernán, MJ Olek, PM Coplan, K Brodovicz, ... New England Journal of Medicine 344 (5), 327-332, 2001 | 638 | 2001 |
| Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory PM Coplan, K Schmader, A Nikas, ISF Chan, P Choo, MJ Levin, ... The Journal of Pain 5 (6), 344-356, 2004 | 363 | 2004 |
| International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for … TC Mast, L Kierstead, SB Gupta, AA Nikas, EG Kallas, V Novitsky, ... Vaccine 28 (4), 950-957, 2010 | 309 | 2010 |
| Abuse rates and routes of administration of reformulated extended-release oxycodone: initial findings from a sentinel surveillance sample of individuals assessed for substance … SF Butler, TA Cassidy, H Chilcoat, RA Black, C Landau, SH Budman, ... The Journal of Pain 14 (4), 351-358, 2013 | 232 | 2013 |
| The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults KE Schmader, R Sloane, C Pieper, PM Coplan, A Nikas, P Saddier, ... The Clinical journal of pain 23 (6), 490-496, 2007 | 182 | 2007 |
| Perceptions of sexual behavior and knowledge about sexually transmitted diseases among adolescents in Benin City, Nigeria MJ Temin, FE Okonofua, FO Omorodion, EP Renne, P Coplan, ... International family planning perspectives, 186-195, 1999 | 174 | 1999 |
| Development of a framework for enhancing the transparency, reproducibility and communication of the benefit–risk balance of medicines PM Coplan, RA Noel, BS Levitan, J Ferguson, F Mussen Clinical Pharmacology & Therapeutics 89 (2), 312-315, 2011 | 165 | 2011 |
| Safety and availability of dapivirine (TMC120) delivered from an intravaginal ring J Romano, B Variano, P Coplan, J Van Roey, K Douville, Z Rosenberg, ... AIDS research and human retroviruses 25 (5), 483-488, 2009 | 160 | 2009 |
| Long-term effectiveness of varicella vaccine: a 14-year, prospective cohort study R Baxter, P Ray, TN Tran, S Black, HR Shinefield, PM Coplan, E Lewis, ... Pediatrics 131 (5), e1389-e1396, 2013 | 159 | 2013 |
| Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended‐release oxycodone with abuse‐deterrent characteristics PM Coplan, H Kale, L Sandstrom, C Landau, HD Chilcoat Pharmacoepidemiology and drug safety 22 (12), 1274-1282, 2013 | 147 | 2013 |
| Reduced abuse, therapeutic errors, and diversion following reformulation of extended-release oxycodone in 2010 SG Severtson, BB Bartelson, JM Davis, A Muñoz, MF Schneider, ... The journal of pain 14 (10), 1122-1130, 2013 | 134 | 2013 |
| Postmarketing evaluation of the safety and effectiveness of varicella vaccine S BLACK, H SHINEFIELD, P RAY, E LEWIS, J HANSEN, J SCHWALBE, ... The Pediatric infectious disease journal 18 (12), 1041-1046, 1999 | 124 | 1999 |
| Postlicensure study of varicella vaccine effectiveness in a day-care setting DA CLEMENTS, SP MOREIRA, PM COPLAN, CL BLAND, EB WALTER The Pediatric infectious disease journal 18 (12), 1047-1050, 1999 | 118 | 1999 |
| Patient characteristics and attitudes associated with antiretroviral (AR) adherence N Wenger, A Gifford, H Liu, M Chesney, C Golin, S Crystal, S BERR, ... 6th Conference on Retroviruses and Opportunistic Infections, 1999 | 108 | 1999 |
| Assessing the accuracy of opioid overdose and poisoning codes in diagnostic information from electronic health records, claims data, and death records CA Green, NA Perrin, SL Janoff, CI Campbell, HD Chilcoat, PM Coplan Pharmacoepidemiology and drug safety 26 (5), 509-517, 2017 | 104 | 2017 |
| Cross-reactivity of anti–HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1–positive individuals from 4 continents PM Coplan, SB Gupta, SA Dubey, P Pitisuttithum, A Nikas, B Mbewe, ... The Journal of infectious diseases 191 (9), 1427-1434, 2005 | 104 | 2005 |
| Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women AM Nel, P Coplan, JH van de Wijgert, SH Kapiga, C von Mollendorf, ... Aids 23 (12), 1531-1538, 2009 | 103 | 2009 |
| Impact of an intervention to improve treatment-seeking behavior and prevent sexually transmitted diseases among Nigerian youths FE Okonofua, P Coplan, S Collins, F Oronsaye, D Ogunsakin, JT Ogonor, ... International Journal of Infectious Diseases 7 (1), 61-73, 2003 | 101 | 2003 |
| The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania SH Kapiga, NE Sam, H Bang, Q Ni, TTH Ao, I Kiwelu, S Chiduo, U Ndibe, ... The Journal of infectious diseases 195 (9), 1260-1269, 2007 | 99 | 2007 |
| Application of the BRAT framework to case studies: observations and insights BS Levitan, EB Andrews, A Gilsenan, J Ferguson, RA Noel, PM Coplan, ... Clinical Pharmacology & Therapeutics 89 (2), 217-224, 2011 | 95 | 2011 |
Shumin ZhangJohnson & JohnsonBestätigte E-Mail-Adresse bei its.jnj.com
